Clinical Trial Update: Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AXR-270 for posterior blepharitis associated with meibomian gland dysfunction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meibomian Gland Dysfunction
• Posterior Blepharitis

Drugs mentioned

• AXR-270

Snippet

Sponsor: AxeroVision, Inc. | Conditions: Posterior Blepharitis, Meibomian Gland Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2023-07-21